Key to immune system's memory revealed

December 19, 2017, Monash University
This is Dr Jasmine Li, Professor Stephen J Turner, Dr Moshe Olshansky, Dr Brendan Russ. Credit: Monash University

Monash University's Biomedicine Discovery Institute scientists have defined a novel molecular 'blueprint' that plays a pivotal part in the immune system's ability to fight disease by 'remembering' infections. Understanding the fine detail of immunological memory potentially opens ways to improve, and to create new vaccines, and to hone treatments that use the immune system to fight disease including cancer.

During a response to the immune system's B and T create , allowing it to develop immunity to future infections and also to gain protection through vaccines, which serve to mimic the sort of immunity induced by the virus or bacteria the is trying to prevent.

The study, led by Professor Stephen Turner, used the influenza virus to investigate how cytotoxic or killer T cells - the 'hit men' for fighting infection - are genetically wired to behave.

"What we found is there's a specific sort of wiring that seems to characterise this type of - it's like an electrical circuit," Professor Turner said.

"We were able to identify specific 'switches' that are used in parts of the genome that actually give T cells their function," he said. "This means we can actually look at ways of going in and rewiring these things ourselves using novel vaccine type strategies," he said.

The gene regulatory mechanisms that control the changes that occur in T cells during infection were previously largely unknown.

The study, which used cutting-edge gene sequencing techniques in animal models of influenza, was published today in the prestigious journal Cell Reports.

The 'blueprint' developed by the team could serve as a benchmark for research, and potentially be used to hone and personalise therapies, Professor Turner said.

"We can design very rational and strategic therapies such as vaccines that target particular pathogens. It might be in the context of HIV, flu or malaria, particularly when you have complex viruses that we don't have vaccines for."

The same mechanisms engaging T cells that are used to fight infection are used to fight cancer and in , he said. The study may also have implications for auto-immune diseases such as multiple sclerosis, type 1 diabetes or coeliac disease, when T cells go awry causing the immune system to attack itself.

Professor Turner and his research group in the Department of Microbiology, which he heads, are furthering the research using and are finding that many of the results are translating well.

Explore further: Understanding T cell activation could lead to new vaccines

Related Stories

Understanding T cell activation could lead to new vaccines

May 30, 2017
Scientists could be one step closer to developing vaccines against viruses such as Zika, West Nile or HIV, according to Penn State College of Medicine researchers.

Scientists find potential mechanism for deadly, sepsis-induced secondary infection

September 14, 2017
In mice, an infection-induced condition known as sepsis may increase the risk of life-threatening secondary infection by preventing recruitment of infection-fighting cells to the skin, according to new research published ...

'Bystander' chronic infections thwart development of immune cell memory

May 15, 2014
Studies of vaccine programs in the developing world have revealed that individuals with chronic infections such as malaria and hepatitis tend to be less likely to develop the fullest possible immunity benefits from vaccines ...

A vaccine candidate that supports immunity where it matters most

October 29, 2015
Almost all infections make us sick by getting past our first line of defense - the sticky mucous surfaces that line our mouths, our eyes, our lungs and our guts. Once through, it's up to the immune cells that reside in our ...

Engineered virus has artificial amino acid allowing it to serve as a vaccine

December 2, 2016
(Medical Xpress)—A team of researchers at Peking University has developed a new type of vaccine that they claim may allow for a new approach to generating live virus vaccines which could conceivably be adapted to any type ...

A new role for an old immune cell may lead to novel therapies for infection and cancer

March 1, 2017
A new study has identified a previously undescribed role for a type of unconventional T cell with the potential to be used in the development of new therapies for infection and cancer.

Recommended for you

A bad influence—the interplay between tumor cells and immune cells

October 16, 2018
Research at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) yielded new insights into the environment surrounding different types of lung tumors, and described how these complex cell ecosystems may in turn ...

Function of neutrophils during tumor progression unraveled

October 15, 2018
Researchers at The Wistar Institute have characterized the function of neutrophils, a type of white blood cells, during early stages of tumor progression, showing that they migrate from the bone marrow to distant sites and ...

Immune health maintained by meticulously ordered DNA

October 15, 2018
Walter and Eliza Hall Institute researchers have revealed how immune health is maintained by the exquisite organisation skills of a protein called Pax5.

New immunotherapy targeting blood-clotting protein

October 15, 2018
Normally, the blood protein fibrin does not enter the brain. But in several neurological disorders, the blood-brain barrier—which keeps large molecules in the blood from entering the brain—becomes abnormally permeable, ...

Enzyme that triggers autoimmune responses from T-cells in patients with MS found

October 11, 2018
A team of researchers from Switzerland, the U.S. and Spain has isolated an enzyme that triggers an autoimmune response from T-cells in patients with MS. In their paper published in the journal Science Translational Medicine, ...

Scientists reveal new cystic fibrosis treatments work best in inflamed airways

October 11, 2018
A new UNC School of Medicine study shows that two cystic fibrosis (CF) drugs aimed at correcting the defected CFTR protein seem to be more effective when a patient's airway is inflamed. This is the first study to evaluate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.